Clinical Trials for Pancreatic Cancer

Find clinical trials for pancreatic cancer. Discover research opportunities and treatment options in your area.

376 Active Trials Found

Showing 376 trials on this page

Page 5 of 19

Atezolizumab + Cabozantinib in Patients w/ Metastatic, Refractory Pancreatic Cancer

NCT ID: NCT04820179

This clinical trial is investigating a new treatment approach for patients with advanced pancreatic cancer that has not responded to previous therapies. The study is looking at a combination of two...

Recruiting

Phase: PHASE2 Type: interventional Locations: Tucson, Arizona, United States

CtDNA-guided Maintenance Therapy in Pancreatic Cancer

NCT ID: NCT07054879

This clinical trial is studying a new way to help patients with pancreatic cancer stay healthy after surgery. Specifically, it looks at whether a medicine called capecitabine, taken by itself, can ...

Recruiting

Type: observational Locations: Nanjing, Jiangsu, China

Pancreatic Cancer and Diabetes Mellitus

NCT ID: NCT06585072

This clinical trial is focused on understanding how surgery for pancreatic cancer may lead to diabetes or pre-diabetes in patients. Researchers want to find out if the rates of these glucose proble...

Recruiting

Type: observational Locations: Shanghai, Shanghai, China

Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer

NCT ID: NCT05277766

The PIPAC NAL-IRI study is a clinical trial looking to find the highest safe dose of a treatment called nanoliposomal irinotecan (Nal-IRI) for patients with advanced cancer that has spread within t...

Recruiting

Phase: PHASE1 Type: interventional Locations: Ghent, East Flanders, Belgium

Hypofractionated Radiotherapy +Chemotherapy+ Camrelizumab as Neoadjuvant Therapy for Pancreatic Cancer

NCT ID: NCT06435260

This clinical trial is investigating a new treatment approach for locally advanced pancreatic cancer. The researchers want to see if a combination of focused radiation therapy, chemotherapy (the AG...

Recruiting

Phase: PHASE2 Type: interventional Locations: Shijiazhuang, Hebei, China

Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer

NCT ID: NCT05013216

This clinical trial is looking at a new treatment called a mutant KRAS-targeted long peptide vaccine, designed for patients who are at high risk of developing pancreatic cancer. The study aims to s...

Recruiting

Phase: PHASE1 Type: interventional Locations: Baltimore, Maryland, United States

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

NCT ID: NCT03175224

The APL-101 clinical trial is exploring a new treatment for patients with advanced lung cancer, specifically those with certain genetic changes called c-Met Exon 14 skipping mutations or MET amplif...

Recruiting

Phase: PHASE2 Type: interventional Locations: Rochester, Minnesota, United States, Madison, Wisconsin, United States +114 more

Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)

NCT ID: NCT05451043

This clinical trial is investigating a new treatment approach for patients with advanced cancers of the pancreas, liver, and bile ducts. It combines two immunotherapy drugs, Durvalumab and Tremelim...

Recruiting

Phase: PHASE2 Type: interventional Locations: Edmonton, Alberta, Canada

Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer

NCT ID: NCT06423963

This clinical trial is looking at a program that combines exercise and nutrition to help patients with pancreatic cancer get ready for surgery. The goal is to see if this "prehabilitation" approach...

Recruiting

Phase: NA Type: interventional Locations: Tampa, Florida, United States

Laparoscopic Pancreaticoduodenectomy

NCT ID: NCT07009119

This clinical trial is studying a type of surgery called laparoscopic pancreaticoduodenectomy (LPD), which is used to treat certain types of pancreatic and periampullary cancers. This surgery is co...

Recruiting

Phase: NA Type: interventional Locations: Minya, Egypt

The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy

NCT ID: NCT06282809

This clinical trial is studying a new treatment called the HistoSonics Edison™ System, which uses a technique called histotripsy to destroy pancreatic adenocarcinoma, a type of pancreatic cancer th...

Recruiting

Phase: NA Type: interventional Locations: Barcelona, Spain, Barcelona, Spain

Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

NCT ID: NCT03556228

This clinical trial is studying a new medication called VMD-928, which is being tested for patients with certain types of advanced cancers and lymphomas that have not responded to standard treatmen...

Recruiting

Phase: PHASE1 Type: interventional Locations: Milwaukee, Wisconsin, United States, Duarte, California, United States +32 more

Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS)

NCT ID: NCT06001268

The STRONG-PCS trial is studying a program designed to support people with pancreatic cancer after they have surgery. This program offers extra help from dietitians to improve nutrition and overall...

Recruiting

Phase: NA Type: interventional Locations: Tampa, Florida, United States

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

NCT ID: NCT06239194

This clinical trial is testing a new treatment called MDX2001 for patients with advanced solid tumors, which are cancers that form in organs or tissues, such as breast, lung, or colorectal cancer. ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Nashville, Tennessee, United States +4 more

Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer

NCT ID: NCT06782932

This clinical trial is exploring a new treatment approach for patients with surgically removable pancreatic cancer. The study aims to find the best and safest dose of a drug called AGEN2373 when co...

Recruiting

Phase: PHASE1 Type: interventional Locations: Baltimore, Maryland, United States

Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source

NCT ID: NCT02843945

This clinical trial is studying a new way to treat borderline resectable pancreatic cancer, which is a type of cancer that can be challenging to remove completely through surgery. The researchers a...

Recruiting

Phase: PHASE1 Type: interventional Locations: Philadelphia, Pennsylvania, United States, Oak Lawn, Illinois, United States +4 more

Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma

NCT ID: NCT04543071

This clinical trial, called Chemo4METPANC, is studying a new treatment approach for patients with pancreatic cancer, specifically pancreatic adenocarcinoma. The researchers want to find out if a co...

Recruiting

Phase: PHASE2 Type: interventional Locations: Providence, Rhode Island, United States, New York, New York, United States +1 more

Safety, Tolerability, Pharmacokinetics, Radiation Dosimetry, and PET Imaging Properties of 89Zr-labeled hNd2 (NMK89) in Patients With Pancreatic Cancer

NCT ID: NCT06129422

This clinical trial is studying a new imaging agent called NMK89, which is designed to help doctors better visualize pancreatic cancer in patients. Specifically, the trial is focused on patients wh...

Recruiting

Phase: PHASE1 Type: interventional Locations: Tampa, Florida, United States, Seattle, Washington, United States +2 more

Bile Omics for Diagnosing Indeterminate Biliary Strictures

NCT ID: NCT07007832

This clinical trial is studying a new way to diagnose certain types of cancer and bile duct problems. Specifically, it focuses on patients with biliary strictures—narrowing of the bile ducts that c...

Recruiting

Type: observational Locations: Shanghai, Shanghai, China, Shanghai, China

Integrated Cancer Repository for Cancer Research

NCT ID: NCT02012699

The Integrated Cancer Repository for Cancer Research (iCaRe2) is a study designed to gather important information and samples from adults who have been diagnosed with cancer, those at high risk for...

Recruiting

Type: observational Locations: Pittsburgh, Pennsylvania, United States, Denver, Colorado, United States +93 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Prostate Cancer View clinical trials → Healthy View clinical trials →

Search All Trials Browse All Conditions